Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of CGRP Receptor Antagonist Formulations in Healthy Adults
NCT07261371Phase 1Completed
- Sponsor
- Pfizer
- Start
- Nov 2025
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in migraine (4 arms), sponsored by Pfizer. Primary endpoints: Area under the Plasma Concentration-Time profile from time 0 extrapolated to infinite time, Area under the Plasma Concentration-Time profile from time 0 to time of last quantifiable data point and 1 more. Started Nov 2025; status: completed.
02
Conditions
migraine
Beyond the preview
Go deeper on NCT07261371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07261371.